Results 181 to 190 of about 38,769 (305)

Pre‐Exercise Galactose or Lactose Reduces Glycaemic Excursions During Exercise in Adults With Type 1 Diabetes: A Randomised, Double‐Blind, Crossover Trial

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To test whether pre‐exercise galactose and lactose reduce glycaemic excursions during exercise compared with dextrose while maintaining protection against hypoglycaemia compared with placebo in adults with Type 1 diabetes Methods In a randomised, double‐blind, 4‐condition crossover trial, 14 adults with Type 1 diabetes completed four 60 ...
Karoline R. Schmidt, Rakel F. Johansen, Simon B. Riis, Mads S. Larsen, Henrik Støvring, Gareth A. Wallis, David Rowlands, Lars C. Gormsen, Esben Søndergaard   +8 more
wiley   +1 more source

SGLT2 inhibitors and incretin-based therapies for metabolic dysfunction-associated steatohepatitis: a systematic review. [PDF]

Eur J Clin Pharmacol
Cruz AM, Lima BCV, de Ferreira JESM, Teles RB.   +3 more
europepmc   +1 more source

Trends in Second‐Line Initiations and Treatment Outcomes Across Age and Frailty Groups in People With Type 2 Diabetes: UK Population‐Based Study, 2019–2024

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To assess contemporary UK trends in second‐line treatment initiations and outcomes across age‐and‐frailty groups in people with type 2 diabetes (T2D). Materials and Methods We studied 117 046 UK adults with T2D initiating second‐line therapy between 2019–2024 (Clinical Practice Research Datalink).
M. M. Dinsdale, K. G. Young, P. Cardoso, L. M. Güdemann, T. T. Jansz, A. P. McGovern, A. G. Jones, E. R. Pearson, A. T. Hattersley, T. J. McKinley, B. M. Shields, J. M. Dennis   +11 more
wiley   +1 more source

SGLT2 inhibitors in heart failure with tricuspid regurgitation: clinical interpretation and future directions. [PDF]

Eur Heart J Cardiovasc Pharmacother
Dong W, Zhou Y, Jiang J.
europepmc   +1 more source

T2D Management Among a Community Clinic Patient Sample After California's May 2022 Medicaid Expansion

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims In May 2022, California expanded its Medicaid program (‘Medi‐Cal’) to all low‐income adults over 50 years, regardless of immigration status. We compare haemoglobin A1c (HbA1c) and body mass index (BMI) among undocumented patients with Type 2 diabetes mellitus (T2D) in a primary care setting before and after the expansion.
Annie E. Ro, Jung Min Choi, Celina Morales, Nicole Tavares Kuhn, Cecilia Wu, Luohua Jiang   +5 more
wiley   +1 more source

SGLT2 Inhibitors and Liver Cirrhosis: Hype or Hope? [PDF]

Life (Basel)
Brusnic O, Onisor DM, Boicean A, Porr C, Sofonea FD, Anderco P, Ichim C.   +6 more
europepmc   +1 more source

Aerobic Exercise Training Increases Circulating sRAGE in Adults With Type 2 Diabetes: Associations With Sheddase Regulation

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Objective Soluble receptor for advanced glycation end‐products (sRAGE) and soluble Toll‐like receptor 4 (sTLR4) are circulating pattern recognition receptor isoforms implicated in inflammatory regulation in type 2 diabetes mellitus (T2DM). This study examined the effects of supervised aerobic exercise training (AET) on circulating sRAGE, sTLR4,
Ryan K. Perkins, Corey E. Mazo, James Shadiow, Pallavi Varshney, Edwin R. Miranda, Victoria R. Miranda, Maggie Eisenberg, Jane E. Nakamura, Elif A. Oral, Jacob M. Haus   +9 more
wiley   +1 more source

The Effects of SGLT2 Inhibitors on Muscle Health in Older Adults: A Systematic Review and Meta-Analysis. [PDF]

Pharmacol Res Perspect
Joongpan W, Boonmuen N, Sinchai P, Lapmanee S, Klamsakul N, Pathomthongtaweechai N.   +5 more
europepmc   +1 more source

SGLT2 Inhibitors in Clinical Practice: Cardiorenal Benefits and Risk of Fungal Infections-A Nephrologist's Perspective. [PDF]

J Clin Med
Andryszkiewicz W, Cichowska Z, Kręcicka M, Zmonarski S.   +3 more
europepmc   +1 more source

Prescribing Trajectories in Type 2 Diabetes in the United States, 2019–2024

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Importance Clinical guidelines for type 2 diabetes (T2D) provide population‐level recommendations, but real‐world treatment patterns evolve dynamically and vary across patients. Understanding longitudinal prescribing trajectories may reveal heterogeneity in care not captured by cross‐sectional analyses.
Tobias S. Lux, Dongkun Lee, Jeff M. Phillips, Julio C. Facelli, Daniel C. Malone, Matthew Wahl, Deepika Reddy, Farrant Sakaguchi, Ramkiran Gouripeddi, Alexander S. Millar, Matthew J. O'Brien, Joshua S. Choi, Jittrapol Sutejitsiri, Kensaku Kawamoto, Polina V. Kukhareva   +14 more
wiley   +1 more source